The global diabetes devices market was valued at US$ 32.4 Bn in 2024 and is projected to reach US$ 70.6 Bn by the end of 2035, expanding at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2035. The growth of the market is largely attributed to the increasing prevalence of diabetes worldwide and the rising demand for efficient monitoring and management solutions. With the global diabetic population continuing to grow, healthcare systems and patients alike are increasingly relying on advanced medical devices to manage blood glucose levels and reduce complications associated with the disease.
Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14
Market Overview
The diabetes devices market includes a wide range of medical technologies designed to help individuals monitor and control blood glucose levels effectively. These devices play a vital role in the management of both Type 1 and Type 2 diabetes and are used by patients across hospitals, clinics, and home care settings. Major device categories include continuous glucose monitoring (CGM) systems, insulin infusion devices such as pumps and pens, and traditional blood glucose meters.
As lifestyle changes, urbanization, and rising obesity rates continue to drive the prevalence of diabetes globally, the need for effective disease management tools is increasing significantly. Diabetes devices enable patients to monitor glucose levels in real time and make informed decisions about insulin dosage, diet, and lifestyle habits.
Technological advancements are also transforming diabetes care. Modern devices are increasingly integrated with mobile health applications, telehealth platforms, and data analytics tools that allow patients and healthcare providers to monitor glucose levels remotely. This digital connectivity is enabling more personalized treatment plans and improving patient engagement in disease management.
Key Market Growth Drivers
Rising Global Prevalence of Diabetes
The growing number of people diagnosed with diabetes worldwide is a primary factor driving the diabetes devices market. According to health organizations, more than 400 million individuals are currently living with diabetes, and the number is expected to increase significantly due to sedentary lifestyles, population growth, and increasing obesity rates.
The rise in both Type 1 and Type 2 diabetes has created a substantial demand for reliable monitoring and treatment solutions. Devices such as continuous glucose monitors, insulin pumps, and smart insulin pens are becoming essential tools for individuals seeking to manage their blood glucose levels effectively.
Growing Demand for Home Healthcare and Self-Management
Another key driver of the diabetes devices market is the growing preference for home healthcare and self-management solutions. Patients increasingly seek convenient and easy-to-use devices that allow them to monitor glucose levels and administer insulin without frequent hospital visits.
Continuous glucose monitoring systems, insulin pumps, and smartphone-connected health applications enable patients to track health data and make informed decisions about their treatment. These technologies empower patients to take greater control of their condition while improving treatment outcomes and quality of life.
Analysis of Key Players
The global diabetes devices market is characterized by intense competition and continuous technological innovation. Leading companies are investing heavily in research and development to introduce advanced products that enhance accuracy, ease of use, and connectivity.
Key players in the market include Insulet Corporation, Medtronic, Tandem Diabetes Care, Inc., SOOIL Developments Co., Ltd, F. Hoffmann-La Roche AG, Ypsomed, Terumo Corporation, MicroTech Medical, Inc., Jiangsu Delfu Co., Ltd., Medtrum Technologies Inc., Novo Nordisk A/S, Sanofi, and Abbott.
Market Challenges & Opportunities
Despite the strong growth outlook, the diabetes devices market faces several challenges. High device costs remain a major barrier, particularly in low- and middle-income countries where healthcare resources may be limited. Access to advanced monitoring systems and insulin delivery devices can be restricted due to affordability issues.
Another challenge is the uneven distribution of healthcare infrastructure and awareness in developing regions. Many patients remain undiagnosed or lack access to proper treatment solutions.
However, these challenges also create opportunities for innovation and market expansion. The development of cost-effective devices, integration of artificial intelligence in monitoring systems, and expansion of telehealth services are expected to open new growth avenues. As healthcare providers emphasize preventive care and chronic disease management, the adoption of advanced diabetes technologies is likely to accelerate.
Recent Developments
In February 2025, DexCom, Inc. launched Dexcom ONE+ in Spain, Belgium, and Poland. It is a customizable continuous glucose monitoring solution consisting of a wearable sensor, a transmitter, and a smartphone-compatible app. The device can be worn on three sites in the body. The water-resistant sensor measures blood glucose levels and sends these CGM readings to smartphones compatible with the Dexcom One application.
In January 2024, Medtronic plc declared that their MiniMed 780G system with Simplera Sync received the CE Mark approval. Simplera Sync is a technology that enhances the user experience through a simplified two-step insertion process. In addition, this new sensor is half the size of its precursors.
Explore our report to uncover in-depth insights – https://www.transparencymarketresearch.com/diabetes-devices-market.html
Market Segmentation
The diabetes devices market can be segmented based on product type and end-use applications.
By Product Type
- Continuous Glucose Monitoring (CGM) Systems
- Insulin Delivery Devices (Pumps, Pens, and Syringes)
- Blood Glucose Monitoring Systems
Among these, insulin delivery devices dominate the market due to their essential role in managing blood glucose levels, particularly among patients with Type 1 diabetes. Insulin pens and pumps are widely used due to their convenience, accuracy, and portability.
By End User
- Hospitals and Clinics
- Home Care Settings
- Diagnostic Centers
The home care segment is witnessing rapid growth due to increasing demand for self-monitoring and remote healthcare solutions.
Regional Outlook
North America holds the leading share of the global diabetes devices market. The region’s dominance is attributed to the high prevalence of diabetes, advanced healthcare infrastructure, and strong adoption of innovative medical technologies.
In addition, favorable reimbursement policies and government initiatives aimed at improving chronic disease management support the growth of diabetes device adoption in the region. Patients in North America are increasingly adopting advanced technologies such as continuous glucose monitors and insulin infusion pumps.
Other regions such as Europe and Asia-Pacific are also witnessing significant growth due to rising diabetes prevalence, expanding healthcare access, and increasing awareness of disease management.
Why Buy This Report?
- Gain detailed insights into the diabetes devices market size and forecast through 2035
- Understand key market drivers, challenges, and emerging opportunities
- Analyze the competitive landscape and strategies of leading companies
- Access comprehensive segmentation and regional analysis
- Support strategic planning and investment decisions with reliable market intelligence
Buy this Premium Research Report for exclusive, in-depth insights – https://www.transparencymarketresearch.com/checkout.php?rep_id=14<ype=S
FAQs
- What is the current size of the diabetes devices market?
The global diabetes devices market was valued at US$ 32.4 Bn in 2024. - What is the expected growth rate of the market?
The market is expected to grow at a CAGR of 7.4% from 2025 to 2035. - What factors are driving the diabetes devices market?
Key drivers include the rising global prevalence of diabetes, increasing demand for home healthcare solutions, and technological advancements in monitoring and insulin delivery devices. - Which region dominates the diabetes devices market?
North America currently leads the global market due to its advanced healthcare infrastructure and high adoption of medical technologies. - Who are the major players in the diabetes devices market?
Major companies include Medtronic, Abbott, Insulet Corporation, Tandem Diabetes Care, F. Hoffmann-La Roche AG, Ypsomed, Terumo Corporation, Novo Nordisk, and Sanofi.
More Trending Reports by Transparency Market Research –
Antibody Optimization Service Market: https://www.transparencymarketresearch.com/antibody-optimization-service-market.html
Lactated Ringers Injection Market: https://www.transparencymarketresearch.com/lactated-ringers-injection-market.html
Automated Nucleic Acid Extraction Market: https://www.transparencymarketresearch.com/automated-nucleic-acid-extraction-market.html
Endovascular Treatment Devices Market: https://www.transparencymarketresearch.com/endovascular-treatment-devices-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Leave a Reply